中 | English | русск
Home
About us
Technology & Platform
Services & Solutions
Product
News
Join us
Contact us
NEWS
Company News
Industry News
Market Activity
Apr 06,2023
How to treat different types of chronic heart failure
SGLT2i dapagliflozin can significantly reduce the risk of worsening heart failure, cardiovascular death and all-cause death in patients with HFrEF. Heart failure (referred to as "heart failure") has become a major clinical and public health problem worldwide due to its high prevalence, high risk of hospitalization and death, and high medical burden caused by the disease.